Traditional NSAIDs Do Not Raise Cardiovascular Risk – JAMA Review
This article was originally published in The Tan Sheet
Executive Summary
The nonselective NSAIDs naproxen and ibuprofen appear neither to increase nor decrease the risk of cardiovascular events, according to a Journal of the American Medical Association data review published online Sept. 12
You may also be interested in...
ADAPT Data Linking Naproxen To Heart Risk Is “Not Reliable” – Nissen
The premature halting of the ADAPT trial and subsequent safety concerns for naproxen were "inappropriate and reflected faulty logic," according to Cleveland Clinic cardiologist Steven Nissen, MD
ADAPT Data Linking Naproxen To Heart Risk Is “Not Reliable” – Nissen
The premature halting of the ADAPT trial and subsequent safety concerns for naproxen were "inappropriate and reflected faulty logic," according to Cleveland Clinic cardiologist Steven Nissen, MD
ADAPT Data Linking Naproxen To Heart Risk Is “Not Reliable” – Nissen
The premature halting of the ADAPT trial and subsequent safety concerns for naproxen were "inappropriate and reflected faulty logic," according to Cleveland Clinic cardiologist Steven Nissen, MD